| Filed On | Filing |
|---|---|
| 23 Oct 2026 |
Form 4: Madaus Martin D, Interim CEO
Gave up 1,294 shares to cover exercise price or tax ($46.6K) |
| 07 Oct 2026 |
8-K: Cost Associated with Exit or Disposal Activities; Material Impairments
On October 5, 2026, the Board of Directors of Azenta, Inc. (the “Company”) approved, and the Company committed to, a restructuring plan (the “Plan”) within the Company’s Multiomics reportable segment. The Plan is intended primarily to co... |
| 23 Sep 2026 |
Form 4: Madaus Martin D, Interim CEO
Gave up 1,456 shares to cover exercise price or tax ($49.9K) |
| 17 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
As previously disclosed in the Company’s Current Report on Form 8-K filed on August 24, 2026, the Board of Directors (the “Board”) of Azenta, Inc. (the “Company”) appointed Dr. Martin D. Madaus as the Company’s Interim President and Chie... |
| 16 Sep 2026 |
Form 4: Madaus Martin D, Interim CEO
Received 36,653 shares as a grant or award |
| 16 Sep 2026 |
Form 4: Martin William E. Iii, President Multiomics
Received 15,272 shares as a grant or award |
| 16 Sep 2026 |
Form 4: Pirogova Olga, SVP and CHRO
Received 15,272 shares as a grant or award |
| 16 Sep 2026 |
Form 4: Lin Lawrence Y., EVP, CFO and Treasurer
Received 30,544 shares as a grant or award |
| 16 Sep 2026 |
Form 4: Starr Ephraim, SVP, Gen Counsel & Secretary
Received 15,272 shares as a grant or award |
| 16 Sep 2026 |
Form 4: Bello Erik J., VP Chief Accounting Officer
Received 4,586 shares as a grant or award |
| 09 Sep 2026 |
Form 3: Bello Erik J., VP Chief Accounting Officer
No securities owned |
| 04 Sep 2026 | 8-K: Regulation FD Disclosure; Other Events |
| 24 Aug 2026 | 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure |
| 11 Aug 2026 |
Form 4: Pirogova Olga, SVP and CHRO
Gave up 1,085 shares to cover exercise price or tax ($34.8K) |
| 11 Aug 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 06 Aug 2026 | 10-Q |
| 04 Aug 2026 |
Form 4: Starr Ephraim, SVP, Gen Counsel & Secretary
Bought 335 shares ($8.1K) |
| 04 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 08 Jul 2026 | 8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +1 more |
| 26 May 2026 | FORM SD |
Loading...
